Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03609398 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine

Study acronym: RVF
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 11, 2021 (before its estimated December 2023 completion). Its status may not reflect the trial's current state.

Record History

  1. 3 versions Re-verified since Oct 10, 2019, no change to tracked fieldsv3-v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Dec 2018 to Oct 4, 2018
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is to collect safety and immunogenicity data for an Rift Valley Fever (RVF) vaccine
Trial Details
NCT Number NCT03609398
Lead Sponsor U.S. Army Medical Research and Development Command
Conditions
(from sponsor)		 Rift Valley Fever
Related terms Rift Valley Fever
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov